Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women's Endocrinology.

Costanzo MorettiMarco BonomiPaola DioneseSilvia FedericiAnna Maria FulghesuJacopo GiannelliRoberta GiordanoLaura GuccioneElisa MaseroliPaolo MoghettiRoberto MioniRosario PivonelloChiara SabbadinCarla ScaroniMassimo TonaccheraNunzia VerdeLinda VignozziAlessandra Gambineri

Published in: Journal of endocrinological investigation (2024)

This consensus statement provides recommendations aimed at guiding healthcare practitioners in the use of inositols for the treatment or prevention of female reproductive disorders. More evidence-based data are needed to definitively establish the usefulness of Myo, the appropriate dosage, and to support the use of D-chiro-inositol (DCI) or a definitive Myo/DCI ratio.

Keyphrases

healthcare
primary care
polycystic ovary syndrome
electronic health record
type diabetes
squamous cell carcinoma
locally advanced
adipose tissue
pregnancy outcomes
social media
data analysis
replacement therapy
breast cancer risk